SCHEMBL6314817

SCHEMBL6314817

NCCCn1c(-c2cccc3ccccc23)nc2cc(Cl)ccc2c1=O

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.62
CASR P41180 3/20 0.53
SMN1; SMN2 Q16637 2/20 0.49
CYP3A4 P08684 2/20 0.49
CYP2C19 P33261 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
KIF11 P52732 2/20 0.45
MAPT P10636 3/20 0.45
NPSR1 Q6W5P4 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
TP53 P04637 1/20 0.43
MAP1LC3B Q9GZQ8 1/20 0.43
KCNH2 Q12809 1/20 0.43
RXFP1 Q9HBX9 1/20 0.42
RXRA P19793 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6308903 0.91 CASR (0.57) EGFRCASRSMN1; SMN2CYP3A4CYP2C19
SCHEMBL6308902 0.88 EGFR (0.64) EGFRCASRSMN1; SMN2CYP3A4CYP2C19
SCHEMBL6308910 0.87 CASR (0.53) EGFRCASRSMN1; SMN2MAPTRXRA
SCHEMBL6314890 0.84 EGFR (0.86) EGFRCASRSMN1; SMN2MAPTTP53
SCHEMBL6307813 0.83 EGFR (0.73) EGFRCASRSMN1; SMN2CYP3A4CYP2C19
SCHEMBL6313171 0.83 EGFR (0.69) EGFRSMN1; SMN2CYP3A4CYP2C19CYP1A2
SCHEMBL6314802 0.82 EGFR (0.83) EGFRCASRSMN1; SMN2MAPTTP53
SCHEMBL6309327 0.82 EGFR (0.51) EGFRCASRSMN1; SMN2CYP3A4CYP2C19
SCHEMBL6308088 0.81 EGFR (0.70) EGFRCASRSMN1; SMN2CYP3A4CYP2C19
SCHEMBL6307536 0.81 CASR (0.52) EGFRCASRSMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6890930-B1 Quinazolinones 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2005-05-10 US disclosed
EP-1216235-A1 QUINAZOLINONES MERCK PATENT GmbH (DE) 2002-06-26 EP disclosed
WO-2001023365-A1 QUINAZOLINONES MERCK PATENT GMBH (DE) 2001-04-05 WO disclosed